Log In
Print
BCIQ
Print
Print this Print this
 

Intravenous Terameprocol, Terameprocol (EM-1421)

Also known as: tetra-O-methyl nordihydroguaiaretic acid

  Manage Alerts
Collapse Summary General Information
Company Erimos Pharmaceutical LLC
DescriptionSmall molecule inhibitor of the production and activation of survivin (intravenous formulation)
Molecular Target Survivin (BIRC5)
Mechanism of ActionSurvivin inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today